Who owns AMPHASTAR PHARMACEUTICALS IN?
- CUSIP Number: 03209rab9
Tip: Access positions for across all investors
Analyze quarterly positions in Amphastar Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Amphastar Pharmaceuticals In stock
Who bought or sold AMPHASTAR PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Context Capital Management | 94M | $85M | 40% | Jun 2026 |
|
| DeepCurrents Investment Group | 45M | $41M | 100% | Jun 2026 |
|
| Oaktree Capital Management | 41M | $37M | 7% | Jun 2026 |
|
| Millennium Management | 34M | $31M | 100% | Jun 2026 |
|
| Empyrean Capital Partners | 24M | $22M | 20% | Jun 2026 |
|
| Nuveen | 22M | $20M | 100% | Jun 2026 |
|
| Camden Asset Management | 15M | $14M | -63% | Jun 2026 |
|
| Fort Baker Capital Management | 13M | $11M | 100% | Jun 2026 |
|
| Capstone Investment Advisors | 10M | $9.2M | 100% | Jun 2026 |
|
| Wellesley Investment Advisors | 8.5M | $7.7B | -67% | Jun 2026 |
|
| Kim | 7.5M | $6.8M | 100% | Jun 2026 |
|
| BlackRock | 6.8M | $6.2M | 24% | Jun 2026 |
|
| Morgan Stanley | 6.6M | $6.0M | -29% | Mar 2026 |
|
| Russell Investments | 6.0M | $5.5M | 6% | Jun 2026 |
|
| Calamos Advisors | 5.0M | $4.5M | -50% | Jun 2026 |
|
| Advent Capital Management | 3.9M | $3.5M | -5% | Jun 2026 |
|
| FMR | 3.8M | $3.4M | -1% | Jun 2026 |
|
| Citigroup | 3.5M | $3.2M | 100% | Mar 2026 |
|
| Pinnacle Holdings | 2.0M | $1.8M | -2% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.2M | $1.1M | 0% | Jun 2026 |
|
| Cutler Capital Management | 835k | $758k | -57% | Jun 2026 |
|
| Zazove Associates | 640k | $581k | 100% | Jun 2026 |
|
| Ubs Global Asset Management Americas | 334k | $303k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 300k | $272k | 0% | Jun 2026 |
|
| Puplava Financial Services | 220k | $201k | 0% | Jun 2026 |
|
| Barclays | 81k | $74k | -65% | Jun 2026 |
|
| Crestwood Advisors | 35k | $32k | 100% | Jun 2026 |
|
| Raymond James Financial | 23k | $21k | -21% | Jun 2026 |
|
| Capital Investment Advisory Services | 16k | $15k | 0% | Jun 2026 |
|
| Leucadia National Corporation | 16k | $15k | 100% | Jun 2026 |
|
| Insigneo Advisory Services | 12k | $11k | 0% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 10k | $9.0k | 100% | Jun 2026 |
|
| Brown Trout Management | 5.4k | $5.0M | 100% | Jun 2026 |
|
| Wells Fargo & Company | 4.0k | $3.6k | 0% | Jun 2026 |
|
| Steward Partners Investment Advisory | 4.0k | $3.6k | 0% | Jun 2026 |
|
| Mercer Global Advisors | 3.0k | $2.7k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 6.00 | $5.4k | 0% | Jun 2026 |
|
Who sold out of Amphastar Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Mar 2026 | 94M | $85M |
| Silverback Asset Management | Mar 2026 | 5.1M | $4.6M |
| Royal Bank of Canada | Mar 2026 | 1.1M | $1.0M |
| CSS | Mar 2026 | 510k | $461k |
| SSI Investment Management | Mar 2026 | 358k | $324k |
| Cetera Investment Advisers | Mar 2026 | 111k | $100k |
| Ares Systematic Credit | Mar 2026 | 100k | $91k |
| Rsm Us Wealth Management | Mar 2026 | 37k | $34k |
| Goldman Sachs Group | Mar 2026 | 16k | $15k |
| Fifth Third Bancorp | Mar 2026 | 11k | $9.9k |